
Pharmaceuticals in Singapore
Description
Pharmaceuticals in Singapore
Summary
Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Singaporean pharmaceuticals market registered revenues of $13.2 billion in 2023, representing a negative compound annual growth rate (CAGR) of 1.2% between 2018 and 2023.
- Singapore captured a share of 3.4% in the Asia-Pacific pharmaceuticals market, in 2023.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts
- What was the size of the Singapore pharmaceuticals market by value in 2023?
- What will be the size of the Singapore pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Singapore's pharmaceuticals market?
Table of Contents
45 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Merck & Co Inc
- 8.2. Pfizer Inc.
- 8.3. Sanofi
- 8.4. Novartis AG
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Singapore pharmaceuticals market value: $ billion, 2018-23
- Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: Singapore pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: Merck & Co Inc: Key Facts
- Table 5: Merck & Co Inc: Annual Financial Ratios
- Table 6: Merck & Co Inc: Key Employees
- Table 7: Merck & Co Inc: Key Employees Continued
- Table 8: Pfizer Inc.: Key Facts
- Table 9: Pfizer Inc.: Annual Financial Ratios
- Table 10: Pfizer Inc.: Key Employees
- Table 11: Pfizer Inc.: Key Employees Continued
- Table 12: Sanofi: Key Facts
- Table 13: Sanofi: Annual Financial Ratios
- Table 14: Sanofi: Key Employees
- Table 15: Sanofi: Key Employees Continued
- Table 16: Novartis AG: Key Facts
- Table 17: Novartis AG: Annual Financial Ratios
- Table 18: Novartis AG: Key Employees
- Table 19: Singapore Size of Population (million), 2019-23
- Table 20: Singapore Real GDP (constant 2010 prices, $ billion), 2019-23
- Table 21: Singapore GDP (current prices, $ billion), 2019-23
- Table 22: Singapore Inflation, 2019-23
- Table 23: Singapore Consumer Price Index (absolute), 2019-23
- Table 24: Singapore Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.